Mostrar el registro sencillo del ítem

dc.contributor.authorCadete, A.
dc.contributor.authorOlivera, A.
dc.contributor.authorBesev, M.
dc.contributor.authorDhal, P. K.
dc.contributor.authorGonçalves, L.
dc.contributor.authorAlmeida, A. J.
dc.contributor.authorBastiat, G.
dc.contributor.authorBenoit, J. P.
dc.contributor.authorDe La Fuente Freire, María 
dc.contributor.authorGarcia-Fuentes, M.
dc.contributor.authorAlonso, M. J.
dc.contributor.authorTorres, D.
dc.date.accessioned2021-09-30T09:19:00Z
dc.date.available2021-09-30T09:19:00Z
dc.date.issued2019
dc.identifier.issn2045-2322
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/31399627es
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689112/pdf/41598_2019_Article_47995.pdfes
dc.identifier.urihttp://hdl.handle.net/20.500.11940/15401
dc.description.abstractPreparation of sophisticated delivery systems for nanomedicine applications generally involve multi-step procedures using organic solvents. In this study, we have developed a simple self-assembling process to prepare docetaxel-loaded hyaluronic acid (HA) nanocapsules by using a self-emulsification process without the need of organic solvents, heat or high shear forces. These nanocapsules, which comprise an oily core and a shell consisting of an assembly of surfactants and hydrophobically modified HA, have a mean size of 130 nm, a zeta potential of -20 mV, and exhibit high docetaxel encapsulation efficiency. The nanocapsules exhibited an adequate stability in plasma. Furthermore, in vitro studies performed using A549 lung cancer cells, showed effective intracellular delivery of docetaxel. On the other hand, blank nanocapsules showed very low cytotoxicity. Overall, these results highlight the potential of self-emulsifying HA nanocapsules for intracellular drug delivery.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshLung Neoplasms*
dc.subject.meshHyaluronic Acid*
dc.subject.meshHumans*
dc.subject.meshDrug Delivery Systems*
dc.subject.meshNanocapsules*
dc.subject.meshAntineoplastic Agents*
dc.titleSelf-assembled hyaluronan nanocapsules for the intracellular delivery of anticancer drugses
dc.typeArtigoes
dc.authorsophosCadete, A.
dc.authorsophosOlivera, A.
dc.authorsophosBesev, M.
dc.authorsophosDhal, P. K.
dc.authorsophosGonçalves, L.
dc.authorsophosAlmeida, A. J.
dc.authorsophosBastiat, G.
dc.authorsophosBenoit, J. P.
dc.authorsophosde la Fuente, M.
dc.authorsophosGarcia-Fuentes, M.
dc.authorsophosAlonso, M. J.
dc.authorsophosTorres, D.
dc.identifier.doi10.1038/s41598-019-47995-8
dc.identifier.pmid31399627
dc.identifier.sophos30607
dc.issue.number1es
dc.journal.titleScientific Reportses
dc.organizationServizo Galego de Saúde
dc.page.initial11565es
dc.rights.accessRightsopenAccess
dc.subject.decsnanocápsulas*
dc.subject.decshumanos*
dc.subject.decssistemas de liberación de medicamentos*
dc.subject.decsneoplasias pulmonares*
dc.subject.decsácido hialurónico*
dc.subject.decsantineoplásicos*
dc.subject.keywordIDIS
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number9es


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional